Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury

Although CEACAM1 (CC1) glycoprotein resides at the interface of immune liver injury and metabolic homeostasis, its role in orthotopic liver transplantation (OLT) remains elusive. We aimed to determine whether/how CEACAM1 signaling may affect hepatic ischemia-reperfusion injury (IRI) and OLT outcomes...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Invest
Autors principals: Nakamura, Kojiro, Kageyama, Shoichi, Kaldas, Fady M., Hirao, Hirofumi, Ito, Takahiro, Kadono, Kentaro, Dery, Kenneth J., Kojima, Hidenobu, Gjertson, David W., Sosa, Rebecca A., Kujawski, Maciej, Busuttil, Ronald W., Reed, Elaine F., Kupiec-Weglinski, Jerzy W.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Clinical Investigation 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7190917/
https://ncbi.nlm.nih.gov/pubmed/32027621
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI133142
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars